Trial Profile
Insulin glargine vs rosiglitazone as add-on therapy in patients failing sulfonylurea and metformin combination therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Rosiglitazone
- Indications Diabetes mellitus; Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Aventis Pharmaceuticals
- 07 Jul 2009 Actual initiation date changed from Sep 2002 to Jun 2002 as reported by ClinicalTrials.gov.
- 14 Sep 2006 New trial record.